Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India

Journal of Gastrointestinal Cancer

Volumn 43, Issue 2, 2012, Pages 196-204

  Ahirwar, Dinesh K ^a   Kesarwani, Pravin ^a   Singh, Ranjana ^a   Ghoshal, Uday Chand ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Crohn's disease; Haplotype; Inflammatory bowel disease; Interleukin 10; Interleukin 4; Polymorphism; Tumor necrosis factor alpha; Ulcerative colitis

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; INTERLEUKIN 10; INTERLEUKIN 4; STEROID; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTOSIGMOIDITIS; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID THERAPY; ULCERATIVE COLITIS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-4; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863878716     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9238-9     Document Type: Article

References (33)

1. Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J Gastroenterol. 2007;26(6):285-9. (Pubitemid 351629632)
2. Das K et al. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2008;54:1099-107.
3. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis. 1998;16(6):351-5. (Pubitemid 128525942)
4. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79-94. (Pubitemid 34052583)
5. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347(6):417-29. (Pubitemid 34851835)
6. Braat H et al. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med. 2005;83(8):601-9. (Pubitemid 41176069)
7. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3(7):521-33. (Pubitemid 37328672)
8. Autschbach F et al. Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in non-inflamed gut and Crohn's disease. Virchows Arch. 1995;426 (1):51-60.
9. Murch SH et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993;34(12):1705-9. (Pubitemid 23353163)
10. Jarnerot G et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128(7):1805-11. (Pubitemid 40824691)
11. Berg DJ et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002;123(5):1527-42. (Pubitemid 35231653)
12. Ferguson LR et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol. 2008;14(29):4652-61.
13. Tedde A et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol. 2008;43(6):712-8. (Pubitemid 351868712)
14. Sood A et al. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut. 2003;52(11):1587-90. (Pubitemid 37363442)
15. Stange EF et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55 Suppl 1:i1-i15. (Pubitemid 43268290)
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
17. Grutters JC et al. Increased frequency of the uncommon tumor necrosis factor -857 T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med. 2002;165(8):1119-24. (Pubitemid 34415821)
18. Perrey C et al. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol. 1999;7(2):127-8. (Pubitemid 29472075)
19. Hegab AE et al. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest. 2004;126(6):1832-9. (Pubitemid 39643987)
20. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12(5):921-7.
21. Wacholder S et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434-42. (Pubitemid 38443646)
22. Yang SK et al. Association of TNF-alpha/LTA polymorphisms with Crohn's disease in Koreans. Cytokine. 2006;35(1-2):13-20.
23. Higuchi T et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51(6):605-12. (Pubitemid 28306464)
24. Udalova IA et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol. 2000;20(24):9113-9. (Pubitemid 32246100)
25. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390-407. (Pubitemid 44018812)
26. Monteleone G et al. New mediators of immunity and inflammation in inflammatory bowel disease. Curr Opin Gastroenterol. 2006;22(4):361-4. (Pubitemid 44090189)
27. Stucchi A et al. A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC. Inflamm Bowel Dis. 2006;12(7):581-7. (Pubitemid 43977739)
28. Reimund JM et al. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol. 1996;16(3):144-50.
29. Martin ER et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet. 2000;67(2):383-94. (Pubitemid 30616743)
30. Buchs N et al. IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxf). 2000;39(10):1126-31.
31. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998;22(4):382-9. (Pubitemid 28113526)
32. Iijima H et al. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J Exp Med. 1999;190(5):607-15. (Pubitemid 29428645)
33. Tagore A et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens. 1999;54(4):386-90. (Pubitemid 29484280)